Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
Hip arthroscopy for femoroacetabular impingement requires bone reshaping and labral repair together; correcting the labrum alone leaves the repair under the same mechanical stress that caused the original tear, while recovery depends on controlled loading, not immobilisation.
AMIC repairs cartilage-only defects with a collagen scaffold anchoring marrow-derived stem cells, while OATS transplants bone-cartilage plugs for lesions extending into subchondral bone; the choice turns on the defect's depth and location.
Corticosteroid hip injections prove no better than placebo, according to a 2025 systematic review. ChondroFiller—a collagen scaffold that gels inside the joint—fills the gap for patients caught between ineffective standard injections and hip replacement.
The surgical route to the hip joint determines which muscles and stabilising tendons are cut or preserved, producing measurably different outcomes. SuperPATH minimises blood loss and incision size; SPAIRE maintains stability by sparing key tendons; the lateral approach causes hip-drop limp from gluteal weakness.
Defect size determines whether hip cartilage repair uses autograft transfer (under 2 cm²), scaffolded microfracture (2–4 cm²), or fresh allograft (larger defects); osteoarthritis at Tönnis grade 2 or above renders all three techniques ineffective, making hip replacement appropriate.
SPAIRE hip replacement keeps the piriformis and obturator internus tendons attached throughout surgery rather than detaching and reattaching them, leaving posterior stability intact from the moment the patient leaves the operating table; suitability depends on hip geometry, BMI, and soft-tissue integrity shown on imaging.
ChondroFiller is a collagen matrix that self-gels within the hip joint and recruits the patient's own progenitor cells to rebuild tissue damage; seventy to eighty-five per cent of patients achieve meaningful pain relief.
Nearly 40 per cent of hip biological injection studies omit any post-procedure protocol; yet structured rehabilitation substantially improves long-term outcomes versus injection alone.
Hip cartilage treatment choice — injection or surgery — depends on four clinical facts established through imaging, not on treatment preference: lesion spread, bone involvement, osteoarthritis grade, and patient age.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
